Evidence of Haloperidol Absorption After Topical Administration
NCT01684969
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
lack of accrual and funding is about to expire.
Conditions
Nausea
Vomiting
Interventions
DRUG:
Haloperidol
DRUG:
Placebo
Sponsor
Eric E. Prommer